{"count": 8, "results": [{"_id": "31905674", "pmid": 31905674, "pmcid": "PMC6982810", "title": "Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis", "journal": "Molecules", "authors": ["Markowicz-Piasecka M", "Huttunen KM", "Sadkowska A", "Sikora J"], "date": "2019-12-28T00:00:00Z", "doi": "10.3390/molecules25010125", "meta_date_publication": "2019 Dec 28", "meta_volume": "25", "meta_issue": "1", "meta_pages": "", "score": 50072.047, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduced @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ manifested by 19.0% decrease in maximum of aggregation (Amax), and 20% reduction in initial @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ velocity (v0). ", "citations": {"NLM": "Markowicz-Piasecka M, Huttunen KM, Sadkowska A, Sikora J. Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis Molecules. 2019 Dec 28;25(1):. PMID: 31905674", "BibTeX": "@article{31905674, title={Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis}, author={Markowicz-Piasecka M and Huttunen KM and Sadkowska A and Sikora J}, journal={Molecules}, volume={25}, number={1}}"}}, {"_id": "2702918", "pmid": 2702918, "title": "Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics.", "journal": "Diabetes Res Clin Pract", "authors": ["Gin H", "Freyburger G", "Boisseau M", "Aubertin J"], "date": "1989-01-03T00:00:00Z", "doi": "10.1016/0168-8227(89)90058-2", "meta_date_publication": "1989 Jan 3", "meta_volume": "6", "meta_issue": "1", "meta_pages": "61-7", "score": 50065.08, "text_hl": "Study of the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ in @GENE_INS @GENE_3630 @@@insulin@@@-dependent @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetics@@@.", "citations": {"NLM": "Gin H, Freyburger G, Boisseau M, Aubertin J. Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics. Diabetes Res Clin Pract. 1989 Jan 3;6(1):61-7. PMID: 2702918", "BibTeX": "@article{2702918, title={Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics.}, author={Gin H and Freyburger G and Boisseau M and Aubertin J}, journal={Diabetes Res Clin Pract}, volume={6}, number={1}, pages={61-7}}"}}, {"_id": "27805009", "pmid": 27805009, "pmcid": "PMC5090250", "title": "Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release", "journal": "Sci Rep", "authors": ["Xin G", "Wei Z", "Ji C", "Zheng H", "Gu J", "Ma L", "Huang W", "Morris-Natschke SL", "Yeh JL", "Zhang R", "Qin C", "Wen L", "Xing Z", "Cao Y", "Xia Q", "Lu Y", "Li K", "Niu H", "Lee KH", "Huang W"], "date": "2016-11-02T00:00:00Z", "doi": "10.1038/srep36222", "meta_date_publication": "2016 Nov 2", "meta_volume": "6", "meta_issue": "", "meta_pages": "36222", "score": 50057.76, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet@@@ activation in vivo and in vitro", "citations": {"NLM": "Xin G, Wei Z, Ji C, Zheng H, Gu J, Ma L, Huang W, Morris-Natschke SL, Yeh JL, Zhang R, Qin C, Wen L, Xing Z, Cao Y, Xia Q, Lu Y, Li K, Niu H, Lee KH, Huang W. Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release Sci Rep. 2016 Nov 2;6():36222. PMID: 27805009", "BibTeX": "@article{27805009, title={Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release}, author={Xin G and Wei Z and Ji C and Zheng H and Gu J and Ma L and Huang W and Morris-Natschke SL and Yeh JL and Zhang R and Qin C and Wen L and Xing Z and Cao Y and Xia Q and Lu Y and Li K and Niu H and Lee KH and Huang W}, journal={Sci Rep}, volume={6}, pages={36222}}"}}, {"_id": "8875085", "pmid": 8875085, "title": "Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.", "journal": "Diabetes Care", "authors": ["Marfella R", "Acampora R", "Verrazzo G", "Ziccardi P", "De Rosa N", "Giunta R", "Giugliano D"], "date": "1996-09-01T00:00:00Z", "doi": "10.2337/diacare.19.9.934", "meta_date_publication": "1996 Sep", "meta_volume": "19", "meta_issue": "9", "meta_pages": "934-9", "score": 50054.87, "text_hl": "The decrease in both @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ and blood viscosity after @CHEMICAL_Arginine @CHEMICAL_MESH:D001120 @@@L-arginine@@@ was significantly amplified after @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Marfella R, Acampora R, Verrazzo G, Ziccardi P, De Rosa N, Giunta R, Giugliano D. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care. 1996 Sep;19(9):934-9. PMID: 8875085", "BibTeX": "@article{8875085, title={Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.}, author={Marfella R and Acampora R and Verrazzo G and Ziccardi P and De Rosa N and Giunta R and Giugliano D}, journal={Diabetes Care}, volume={19}, number={9}, pages={934-9}}"}}, {"_id": "20095396", "pmid": 20095396, "title": "[Antiaggregant activity of hypoglycemic drugs].", "journal": "Eksp Klin Farmakol", "authors": ["Spasov AA", "Kucheriavenko AF", "Maĭstrenko BP"], "date": "2009-11-01T00:00:00Z", "meta_date_publication": "2009 Nov-Dec", "meta_volume": "72", "meta_issue": "6", "meta_pages": "27-9", "score": 50045.92, "text_hl": "We have compared the inhibitory effects of a series of hypoglycemic drugs, including @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@glyclazide@@@, @CHEMICAL_Glyburide @CHEMICAL_MESH:D005905 @@@glibenclamide@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@glucophage@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_9_diethylaminoethyl_2_3_dihydroimidazo(1_2alpha)benzimidazole @CHEMICAL_MESH:C501282 @@@diabenol@@@ (a new antidiabetic drug), and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@acetylsalicylic acid@@@ (reference antiaggregant preparation), on @SPECIES_9986 @@@rabbit@@@ @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@ in vitro induced by adding 5 mM @CHEMICAL_Adenosine_Diphosphate @CHEMICAL_MESH:D000244 @@@ADP@@@ solution. ", "citations": {"NLM": "Spasov AA, Kucheriavenko AF, Maĭstrenko BP. [Antiaggregant activity of hypoglycemic drugs]. Eksp Klin Farmakol. 2009 Nov-Dec;72(6):27-9. PMID: 20095396", "BibTeX": "@article{20095396, title={[Antiaggregant activity of hypoglycemic drugs].}, author={Spasov AA and Kucheriavenko AF and Maĭstrenko BP}, journal={Eksp Klin Farmakol}, volume={72}, number={6}, pages={27-9}}"}}, {"_id": "16219011", "pmid": 16219011, "title": "Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.", "journal": "Diabetes Obes Metab", "authors": ["Bailey CJ"], "date": "2005-11-01T00:00:00Z", "doi": "10.1111/j.1463-1326.2005.00497.x", "meta_date_publication": "2005 Nov", "meta_volume": "7", "meta_issue": "6", "meta_pages": "675-91", "score": 50044.71, "text_hl": "Basal @GENE_INS @GENE_3630 @@@insulin@@@ concentrations are not raised by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@, so there is minimal risk of hypoglycaemia, and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can reduce the @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ associated with @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@. ", "citations": {"NLM": "Bailey CJ. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones. Diabetes Obes Metab. 2005 Nov;7(6):675-91. PMID: 16219011", "BibTeX": "@article{16219011, title={Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.}, author={Bailey CJ}, journal={Diabetes Obes Metab}, volume={7}, number={6}, pages={675-91}}"}}, {"_id": "25993908", "pmid": 25993908, "title": "Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity.", "journal": "Thromb Haemost", "authors": ["Randriamboavonjy V", "Mann WA", "Elgheznawy A", "Popp R", "Rogowski P", "Dornauf I", "Dröse S", "Fleming I"], "date": "2015-08-31T00:00:00Z", "doi": "10.1160/TH14-09-0797", "meta_date_publication": "2015 Aug 31", "meta_volume": "114", "meta_issue": "3", "meta_pages": "569-78", "score": 50044.703, "text_hl": "In @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin-resistant@@@ @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_9606 @@@patients@@@ (HOMA-IR> 2) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment (1.7 g per day for 4 weeks to 6 months) improved @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity, restored mitochondrial integrity and function and normalised @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet aggregation@@@. ", "citations": {"NLM": "Randriamboavonjy V, Mann WA, Elgheznawy A, Popp R, Rogowski P, Dornauf I, Dröse S, Fleming I. Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity. Thromb Haemost. 2015 Aug 31;114(3):569-78. PMID: 25993908", "BibTeX": "@article{25993908, title={Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity.}, author={Randriamboavonjy V and Mann WA and Elgheznawy A and Popp R and Rogowski P and Dornauf I and Dröse S and Fleming I}, journal={Thromb Haemost}, volume={114}, number={3}, pages={569-78}}"}}, {"_id": "21527115", "pmid": 21527115, "title": "The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.", "journal": "J Diabetes Sci Technol", "authors": ["Schöndorf T", "Musholt PB", "Hohberg C", "Forst T", "Lehmann U", "Fuchs W", "Löbig M", "Müller J", "Pfützner A"], "date": "2011-03-01T00:00:00Z", "doi": "10.1177/193229681100500233", "meta_date_publication": "2011 Mar 1", "meta_volume": "5", "meta_issue": "2", "meta_pages": "426-32", "score": 50042.098, "text_hl": "This study investigates the impact of a @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy on biomarkers of @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ and @<m>DISEASE_Blood_Platelet_Disorders</m> @DISEASE_MESH:D001791 @@@platelet activation@@@ in comparison to a treatment with @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@ plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Schöndorf T, Musholt PB, Hohberg C, Forst T, Lehmann U, Fuchs W, Löbig M, Müller J, Pfützner A. The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study. J Diabetes Sci Technol. 2011 Mar 1;5(2):426-32. PMID: 21527115", "BibTeX": "@article{21527115, title={The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.}, author={Schöndorf T and Musholt PB and Hohberg C and Forst T and Lehmann U and Fuchs W and Löbig M and Müller J and Pfützner A}, journal={J Diabetes Sci Technol}, volume={5}, number={2}, pages={426-32}}"}}]}